Suppr超能文献

左心室功能障碍和植入式心脏复律除颤器患者中,植入前低钠血症对发病率和死亡率的预后影响。

The prognostic impact of pre-implantation hyponatremia on morbidity and mortality among patients with left ventricular dysfunction and implantable cardioverter-defibrillators.

机构信息

Division of Cardiology, Section of Heart Rhythm Management and the Evidence Based Practice Center, Hartford Hospital, University of Connecticut School of Medicine, 80 Seymour Street, Hartford, CT 06102-5037, USA.

出版信息

Europace. 2014 Jan;16(1):47-54. doi: 10.1093/europace/eut211. Epub 2013 Aug 16.

Abstract

AIMS

Hyponatremia is commonly observed among patients with left ventricular (LV) dysfunction and is a marker for adverse outcomes. We aimed to determine the prognostic significance of pre-implant hyponatremia on the outcomes of death, acute decompensated heart failure (ADHF) and appropriate implantable cardioverter-defibrillator (ICD) therapy for ventricular arrhythmias among patients with ICDs.

METHODS AND RESULTS

The study population consisted of patients with an ejection fraction ≤40% undergoing ICD implantation (n = 911) for the primary or secondary prevention of sudden cardiac death from 1997 to 2007. The predictive value of the severity of pre-implantation hyponatremia stratified into mild hyponatremia (n = 268, sodium 134-136 mmol/L), moderate hyponatremia (n = 105, sodium 131-133 mmol/L), and severe hyponatremia (n = 31, sodium ≤130 mmol/L) on the risk of death, ADHF, and appropriate ICD therapy for ventricular arrhythmias as compared with patients a normal serum sodium (n = 507, sodium ≥ 137 mmol/L), was calculated using multivariable Cox proportional hazards analyses. During a mean follow-up of 775 ± 750 days as the severity of hyponatremia (from a normal sodium to severe hyponatremia) increased an incremental incidence of death (25% to 61%, P < 0.001) and ADHF (11% to 26%, P = 0.004) was observed with a reduced incidence of ICD therapy for ventricular tachycardia/ventricular fibrillation (37-29%, P = 0.037). Compared with the normal sodium cohort, patients with severe hyponatremia demonstrated an increased risk of death [adjusted hazard ratio (AHR) 2.69 (95% confidence interval, CI 1.57-4.59), P = 0.004] and ADHF [AHR 2.98 (95% CI 1.41-6.30), P = 0.004], with a lower probability of appropriate ICD therapy [AHR 0.68 (95% CI 0.27-0.88), P = 0.031].

CONCLUSION

Hyponatremia is commonly observed among ICD recipients with LV dysfunction. Patients with an increasing severity of hyponatremia are at increased risk of death and HF related morbidity with a reduced incidence of appropriate ICD therapy particularly among patients with severe hyponatremia.

摘要

目的

低钠血症在左心室(LV)功能障碍患者中很常见,是不良预后的标志物。我们旨在确定植入前低钠血症对植入式心律转复除颤器(ICD)患者因室性心律失常进行死亡、急性失代偿性心力衰竭(ADHF)和适当的 ICD 治疗的结局的预测意义。

方法和结果

该研究人群包括 1997 年至 2007 年因原发性或继发性预防心源性猝死而接受 ICD 植入术(n=911)的射血分数≤40%的患者。使用多变量 Cox 比例风险分析计算植入前低钠血症严重程度分层为轻度低钠血症(n=268,钠 134-136mmol/L)、中度低钠血症(n=105,钠 131-133mmol/L)和重度低钠血症(n=31,钠≤130mmol/L)对死亡、ADHF 和适当的 ICD 治疗室性心律失常风险的预测价值,与血清钠正常(n=507,钠≥137mmol/L)的患者相比。在平均 775±750 天的随访期间,随着低钠血症严重程度(从正常钠到重度低钠血症)的增加,观察到死亡率(25%至 61%,P<0.001)和 ADHF(11%至 26%,P=0.004)的递增发生率,ICD 治疗室性心动过速/心室颤动的发生率降低(37-29%,P=0.037)。与正常钠组相比,重度低钠血症患者的死亡风险增加[校正后的危险比(AHR)2.69(95%置信区间,CI 1.57-4.59),P=0.004]和 ADHF [AHR 2.98(95%CI 1.41-6.30),P=0.004],适当的 ICD 治疗的可能性降低[AHR 0.68(95%CI 0.27-0.88),P=0.031]。

结论

低钠血症在 LV 功能障碍的 ICD 接受者中很常见。低钠血症严重程度增加的患者死亡和与 HF 相关的发病率风险增加,适当的 ICD 治疗的发生率降低,尤其是在重度低钠血症患者中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验